Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Up 1.1% – Here’s Why

Bayer Aktiengesellschaft (ETR:BAYN) shares traded up 1.1% during trading on Wednesday . The stock traded as high as €49.55 and last traded at €49.55. Approximately 1,613,123 shares were traded during trading, The stock had previously closed at €49.03.

Bayer Aktiengesellschaft Stock Up 1.1%

The business has a fifty day simple moving average of €48.42 and a two-hundred day simple moving average of €42.97. The company has a current ratio of 1.04, a quick ratio of 0.72 and a debt-to-equity ratio of 129.90. The company has a market cap of $50.02 billion, a PE ratio of -56.85, a price-to-earnings-growth ratio of 36.39 and a beta of 0.83.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.